Comparative metabolic and hepatic effects of GLP-1-based mono-, dual-, and triple-agonist therapies GLP-1 receptor signaling Intestinal L-cells serve as the primary source of GLP-1 synthesis, which operates via G-protein coupled receptors present in pancreatic beta cells, gastrointestinal and central neural systems, cardiac tissues, and kidneys [26]
While important to know about, this warning is based on animal studies and the link has not been found in humans
Diabetes Res Clin Pract 174:108737 [DOI] [PubMed] [Google Scholar] Ke Z, Ma Q, Ye X, Wang Y, Jin Y, Zhao X et al (2024) Peptide GLP-1 receptor agonists: from injection to oral delivery strategies
While the new messaging seems to be that obesity is a genetic disease that we can manage with drugs, theres undoubtedly more to why conditions stemming from metabolic syndrome werent so common half a century ago
When you inject semaglutide, it binds exclusively to GLP-1 receptors throughout your body
Not approved for human consumption, diagnosis, or therapeutic application